HBV Mutation Detail Information

> T184A Search Result


Mutation Information
Mutation Site T184A
Mutation Type Amino acid level
Gene/Protein/Region Type RT
Relevant Drug lamivudine (LAM)
Country USA
Literature Information
PubMed PMID 23114756
Clinical information Yes
Disease HBV infection
Published Year 2013
Journal Antimicrobial agents and chemotherapy
Title Low-level persistence of drug resistance mutations in hepatitis B virus-infected subjects with a past history of Lamivudine treatment.
Author Margeridon-Thermet S,Svarovskaia ES,Babrzadeh F,Martin R,Liu TF,Pacold M,Reuman EC,Holmes SP,Borroto-Esoda K,Shafer RW
Evidence HBV NRTI resistance mutations were defined as rtL80I/V, rtI169T, rtV173L, rtL180M, rtA181T/V, rtT184S/A/I/L/F/G, rtS202G/I, rtM204I/V/S, rtN236T, and rtM250V (1, 2).

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation